Induction and regulation of IFNs during viral infections

Journal of Interferon and Cytokine Research

Volumn 24, Issue 8, 2004, Pages 439-454

  Malmgaard, Lene ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 2; ANTIGEN; BETA INTERFERON; CYTOKINE; DNA; ENVELOPE PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5 PROTEIN; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 18; INTERLEUKIN 2; JANUS KINASE; MANNOSE RECEPTOR; MEMBRANE RECEPTOR; PROTEIN; RNA; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALPHA INTERFERON GENE; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; APOPTOSIS; BETA INTERFERON GENE; CELL ACTIVITY; CELL TYPE; CPG ISLAND; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; FEEDBACK SYSTEM; GENE; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; INFLUENZA VIRUS; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; T LYMPHOCYTE; VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; ORGAN SPECIFICITY; TRANSCRIPTION, GENETIC; VIRUS DISEASES;

HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; JANUS; SIMPLEXVIRUS;

EID: 4344658402     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/1079990041689665     Document Type: Review

References (203)

1. SEN, G.C. (2001). Viruses and interferons. Annu. Rev. Microbiol. 55, 255-281.
2. KOTENKO, S.V., GALLAGHER, G., BAURIN, V.V., LEWIS-ANTES, A., SHEN, M., SHAH, N.K., LANGER, J.A., SHEIKH, F., DICKENSHEETS, H., and DONNELLY, R.P. (2003). IFN-lambdas mediate antiviral protection through a distinct class Ii cytokine receptor complex. Nat. Immunol. 4, 69-77.
3. BRAGANCA, J., and CIVAS, A. (1998). Type I interferon gene expression: differential expression of IFN-α genes induced by viruses and double-stranded RNA. Biochimie 80, 673-687.
4. WATHELET, M.G., LIN, C.H., PAREKH, B.S., RONCO, L.V., HOWLEY, P.M., and MANIATIS, T. (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1, 507-518.
5. SCHAFER, S.L., LIN, R., MOORE, P.A., HISCOTT, J., and PITHA, P.M. (1998). Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273, 2714-2720.
6. BARNES, B.J., MOORE, P.A., and PITHA, P.M. (2001). Virus-specific activation of a novel interferon regulatory fetor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276, 23382-23390.
7. AU, W.C., and PITHA, P.M. (2001). Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon-α promoters. J. Biol. Chem. 276, 41629-41637.
8. AU, W.C., MOORE, P.A., LAFLEUR, D.W., TOMBAL, B., and PITHA, P.M. (1998). Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon-A genes. J. Biol. Chem. 273, 29210-29217.
9. JUANG, Y., LOWTHER, W., KELLUM, M., AU, W.C., LIN, R., HISCOTT, J., and PITHA, P.M. (1998). Primary activation of interferon-α and interferon-β gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95, 9837-9842.
10. MARIE, I., DURBIN, J.E., and LEVY, D.E. (1998). Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17, 6660-6669.
11. LIN, R., GENIN, P., MAMANE, Y., and HISCOTT, J. (2000). Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20, 6342-6353.
12. CHU, W.M., OSTERTAG, D., LI, Z.W., CHANG, L., CHEN, Y., HU, Y., WILLIAMS, B., PERRAULT, J., and KARIN, M. (1999). JNK2 and IκKbeta are required for activating the innate response to viral infection. Immunity 11, 721-731.
13. AU, W.C., MOORE, P.A., LOWTHER, W., JUANG, Y.T., and PITHA, P.M. (1995). Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92, 11657-11661.
14. WEAVER, B.K., KUMAR, K.P., and REICH, N.C. (1998). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359-1368.
15. LIN, R., HEYLBROECK, C., PITHA, P.M., and HISCOTT, J. (1998). Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996.
16. YONEYAMA, M., SUHARA, W., FUKUHARA, Y., FUKUDA, M., NISHIDA, E., and FUJITA, T. (1998). Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CPB/p300. EMBO J. 17, 1087-1095.
17. FITZGERALD, K.A., McWHIRTER, S.M., FAIA, K.L., ROWE, D.C., LATZ, E., GOLENBOCK, D.T., COYLE, A.J., LIAO, S.M., and MANIATIS, T. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496.
18. SHARMA, S., TENOEVER, B.R., GRANDVAUX, N., ZHOU, G.P., LIN, R., and HISCOTT, J. (2003). Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151.
19. SATO, M., HATA, N., ASAGIRI, M., NAKAYA, T., TANIGUCHI, T., and TANAKA, N. (1998). Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441, 106-110.
20. AU, W.C., YEOW, W.S., and PITHA, P.M. (2001). Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 280, 273-282.
21. MARIE, I., SMITH, E., PRAKASH, A., and LEVY, D.E. (2000). Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol. Cell. Biol. 20, 8803-8814.
22. LIN, R., MAMANE, Y., and HISCOTT, J. (2000). Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275, 34320-34327.
23. BARNES, B.J., KELLUM, M.J., FIELD, A.E., and PITHA, P.M. (2002). Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 22, 5721-5740.
24. BARNES, B.J., FIELD, A.E., and PITHA-ROWE, P.M. (2003). Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFN-α enhanceosome in vivo and transcriptional activity of IFN-α genes. J. BIol. Chem. 278, 16630-16641.
25. SILVERMAN, N., and MANIATIS, T. (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321-2342.
26. SANTORO, M.G., ROSSI, A., and AMICI, C. (2003). NF-kappaB and virus infection: who controls whom. EMBO J. 22, 2552-2560.
27. MOGENSEN, T.H., and PALUDAN, S.R. (2001). Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 65, 131-150.
28. WISDOM, R. (1999). AP-1: one switch for many signals. Exp. Cell Res. 253, 180-185.
29. KARIN, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
30. BINETRUY, B., SMEAL, T., and KARIN, M. (1991). Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351, 122-127.
31. GUPTA, S., CAMPBELL, D., DERIJARD, B., and DAVIS, R.J. (1995). Transcription factor ATF2 regulation by the INK signal transduction pathway. Science 267, 389-393.
32. FREVEL, M.A., BAKHEET, T., SILVA, A.M., HISSONG, J.G., KHABAR, K.S., and WILLIAMS, B.R. (2003). p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell. Biol. 23, 425-436.
33. WINZEN, R., KRACHT, M., RITTER, B., WILHELM, A., CHEN, C.Y., SHYU, A.B., MULLER, M., GAESTEL, M., RESCH, K., and HOLTMANN, H. (1999). The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18, 4969-4980.
34. MILONE, M.C., and FITZGERALD-BOCARSLY, P. (1998). The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses. J. Immunol. 161, 2391-2399.
35. ALEXOPOULOU, L., HOLT, A.C., MEDZHITOV, R., and FLAVELL, R.A. (2001). Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413, 732-738.
36. MALMGAARD, L., SALAZAR-MATHER, T.P., LEWIS, C.A., and BIRON, C.A. (2002). Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/Stat1 system-dependent and -independent pathways. J. Virol. 76, 4520-4525.
37. DALOD, M., SALAZAR-MATHER, T.P., MALMGAARD, L., LEWIS, C., ASSELIN-PATUREL, C., BRIERE, F., TRINCHIERI, G., and BIRON, C.A. (2002). Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517-528.
38. STEWART, W.E., GOSSER, L.B., and LOCKART, R.Z., Jr. (1971). Priming: a nonantiviral function of interferon. J. Virol. 7, 792-801.
39. ERLANDSSON, L., BLUMENTHAL, R., ELORANTA, M.L., ENGEL, H., ALM, G., WEISS, S., and LEANDERSON, T. (1998). Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr. Biol. 8, 223-226.
40. SATO, M., SUEMORI, H., HATA, N., ASAGIRI, M., OGASAWARA, K., NAKAO, K., NAKAYA, T., KATSUKI, M., NOGUCHI, S., TANAKA, N., and TANIGUCHI, T. (2000). Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13, 539-548.
41. BARCHET, W., CELLA, M., ODERMATT, B., ASSELIN-PATUREL, C., COLONNA, M., and KALINKE, U. (2002). Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 196, 507-516.
42. HATA, N., SATO, M., TAKAOKA, A., ASAGIRI, M., TANAKA, N., and TANIGUCHI, T. (2001). Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus. Biochem. Biophys. Res. Commun. 285, 518-525.
43. IZAGUIRRE, A., BARNES, B.J., AMRUTE, S., YEOW, W.S., MEGJUGORAC, N., DAI, J., FENG, D., CHUNG, E., PITHA, P.M., and FITZGERALD-BOCARSLY, P. (2003). Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukocyte Biol. 74, 1125-1138.
44. ASSELIN-PATUREL, C., BOONSTRA, A., DALOD, M., DURAND, I., YESSAAD, N., DEZUTTER-DAMBUYANT, C., VICARI, A., O'GARRA, A., BIRON, C., BRIERE, F., and TRINCHIERI, G. (2001). Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immnol. 2, 1144-1150.
45. KERKMANN, M., ROTHENFUSSER, S., HORNUNG, V., TOWAROWSKI, A., WAGNER, M., SARRIS, A., GIESE, T., ENDRES, S., and HARTMANN, G. (2003). Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plaasmacytoid dendritic cells. J. Immunol. 170, 4465-4474.
46. DALOD, M., HAMILTON, T., SALOMON, R., SALAZAR-MATHER, T.P., HENRY, S.C., HAMILTON, J.D., and BIRON, C.A. (2003). Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197, 885-898.
47. NAYLOR, S.L., SAKAGUCHI, A.Y., SHOWS, T.B., LAW, M.L., GOEDDEL, D.V., and GRAY, P.W. (1983). Human immune interferon gene is located on chromosome 12. J. Exp. Med. 157, 1020-1027.
48. NAYLOR, S.L., GRAY, P.W., and LALLEY, P.A. (1984). Mouse immune interferon (IFN-gamma) gene is on chromosome 10. Somatic Cell Mol. Genet. 10, 531-534.
49. YOUNG, H.A. (1996). Regulation of interferon-gamma gene expression. J. Interferon Cytokine Res. 16, 563-568.
50. GRAY, P.W., and GOEDDEL, D.V. (1982). Structure of the human immune interferon gene. Nature 298, 859-863.
51. TSUJI-TAKAYAMA, K., AIZAWA, Y., OKAMOTO, I., KOJIMA, H., KOIDE, K., TAKEUCHI, M., IKEGAMI, H., OHTA, T., and KURIMOTO, M. (1999). Interleukin-18 induces interferon-gamma production through NF-kappaB and NFAT activation in murine T helper type 1 cells. Cell. Immunol. 196, 41-50.
52. SICA, A., DORMAN, L., VIGGIANO, V., CIPPITELLI, M., GHOSH, P., RICE, N., and YOUNG, H.A. (1997). Interaction of KF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 272, 30412-30420.
53. SICA, A., TAN, T.H., RICE, N., KRETZSCHMAR, M., GHOSH, P., and YOUNG, H.A. (1992). The c-rel proto-oncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc. Natl. Acad. Sci. USA 89, 1740-1744.
54. PENIX, L., WEAVER, W.M., PANG, Y., YOUNG, H.A., and WILSON, C.B. (1993). Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J. Exp. Med. 178, 1483-1496.
55. PENIX, L.A., SWEETSER, M.T., WEAVER, W.M., HOEFFLER, J.P., KERPPOLA, T.K., and WILSON, C.B. (1996). The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J. Biol. Chem. 271, 31964-31972.
56. YE, J., CIPPITELLI, M., DORMAN, L., ORTALDO, J.R., and YOUNG, H.A. (1996). The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms inhibition of AP1 binding and activation of a silencer element. Mol. Cell. Biol. 16, 4744-4753.
57. SZABO, S.J., KIM, S.T., COSTA, G.L., ZHANG, X., FATHMAN, C.G., and GLIMCHER, L.H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100, 655-669.
58. OUYANG, W., RANGANATH, S.H., WEINDEL, K., BHATTACHARYA, D., MURPHY, T.L., SHA, W.C., and MURPHY, K.M. (1998). Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755.
59. GONSKY, R., DEEM, R.L., BREAM, J.H., LEE, D.H., YOUNG, H.A., and TARGAN, S.R. (2000). Mucosa-specific targets for regulation of IFN-gamma expression: lamina propria T cells use different cis-elements than peripheral blood T cells to regulate transactivation of IFN-gamma expression. J. Immunol. 164, 1399-1407.
60. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29, 548-555.
61. (+) T cells. J. Exp. Med. 189, 1355-1360.
62. YANG, J., ZHU, H., MURPHY, T.L., OUYANG, W., and MURPHY, K.M. (2001). IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat. Immunol. 2, 157-164.
63. MALMGAARD, L., PALUDAN, S.R., MOGENSEN, S.C., and ELLERMANN-ERIKSEN, S. (2000). Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involvng NF-kappaB. J. Gen. Virol. 81, 3011-3020.
64. + Th 1 cell development and resistance to Leishmania major. J. Immunol. 170, 1995-2003.
65. TATO, C.M., VILLARINO, A., CAAMANO, J.H., BOOTHBY, M., and HUNTER, C.A. (2003). Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. J. Immunol. 170, 3139-3146.
66. HOGAN, P.G., CHEN, L., NARDONE, J., and RAO, A. (2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232.
67. KIANI, A., GARCIA-COZAR, F.J., HABERMANN, I., LAFORSCH, S., AEBISCHER, T., EHNINGER, G., and RAO, A. (2001). Regulation of interferon-gamma gene expression by nuclear factor of activated T cells. Blood 98, 1480-1488.
68. KISSELEVA, T., BHATTACHARYA, S., BRAUNSTEIN, J., and SCHINDLER, C.W. (2002). Signaling through the Jak/Stat pathway, recent advances and future challenges. Gene 285, 1-24.
69. XU, X., SUN, Y.L., and HOEY, T. (1996). Cooperative DNA binding and sequence-selective recognition conferred by the Stat amino-terminal domain. Science 273, 794-797.
70. NGUYEN, K.B., WATFORD, W.T., SALOMON, R., HOFMANN, S.R., PIEN, G.C., MORINOBU, A., GADINA, M., O'SHEA, J.J., and BIRON, C.A. (2002). Critical role for Stat4 activation by type I interferons in the interferon-gamma response to viral infection. Science 297, 2063-2066.
71. THIERFELDER, W.E., VAN DEURSEN, J.M., YAMAMOTO, K., TRIPP, R.A., SARAWAR, S.R., CARSON, R.T., SANGSTER, M.Y., VIGNALI, D.A., DOHERTY, P.C., GROSVELD, G.C., and IHLE, J.N. (1996). Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
72. KAPLAN, M.H., SUN, Y.L., HOEY, T., and GRUSBY, M.J. (1996). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
73. SCHINDLER, H., LUTZ, M.B., ROLLINGHOFF, M., and BOGDAN, C. (2001). The production of IFN-gamma by IL-12/IL-18-activated macrophages requires Stat4 signaling and is inhibited by IL-4. J. Immunol. 166, 3075-3082.
74. BOT, A., RODRIGO, E., WOLFE, T., BOT, S., and VON HERRATH, M.G. (2003). Infection-triggered regulatory mechanisms override the role of Stat4 in control of the immune response to influenza virus antigens. J. Virol. 77, 5794-5800.
75. KAPLAN, M.H., WURSTER, A.L., and GRUSBY, M.J. (1998). A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J. Exp. Med. 188, 1191-1196.
76. FARRAR, J.D., SMITH, J.D., MURPHY, T.L., and MURPHY, K.M. (2000). Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2. J. Biol. Chem. 275, 2693-2697.
77. FARRAR, J.D., SMITH, J.D., MURPHY, T.L., LEUNG, S., STARK, G.R., and MURPHY, K.M. (2000). Selective loss of type I interferon-induced Stat4 activation caused by a minisatellite insertion in mouse Stat2. Nat. Immunol. 1, 65-69.
78. NGUYEN, K.B., SALAZAR-MATHER, T.P., DALOD, M.Y., VAN DEUSEN, J.B., WEI, X.Q., LIEW, F.Y., CALIGIURI, M.A., DURBIN, J.E., and BIRON, C.A. (2002). Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169, 4279-4287.
79. SZABO, S.J., SULLIVAN, B.M., PENG, S.L., and CLIMCHER, L.H. (2003). Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713-758.
80. ZHENG, W., and FLAVELL, R.A. (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596.
81. FERBER, I.A., LEE, H.J., ZONIN, F., HEATH, V., MUI, A., ARAI, N., and O'GARRA, A. (1999). GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91, 134-144.
82. USUI, T., NISHIKOMORI, R., KITANI, A., and STROBER, W. (2003). GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity. 18, 415-428.
83. CHO, J.Y., GRIGURA, V., MURPHY, T.L., and MURPHY, K. (2003). Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-gamma promoter. Int. Immunol. 15, 1149-1160.
84. SOUTTO, M., ZHANG, F., ENERSON, B., TONG, Y., BOOTHBY, M., and AUNE, T.M. (2002). A minimal IFN-gamma promoter confers Th1 selective expression. J. Immunol. 169, 4205-4212.
85. SZABO, S.J., SULLIVAN, B.M., STEMMANN, C., SATOSKAR, A.R., SLECKMAN, B.P., and GLIMCHER, L.H. (2002). Distinct effects of T-bet in Th1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338-342.
86. MULLEN, A.C., HIGH, F.A., HUTCHINS, A.S., LEE, H.W., VILLARINO, A.V., LIVINGSTON, D.M., KUNG, A.L., CEREB, N., YAO, T.P., YANG, S.Y., and REINER, S.L. (2001). Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 292, 1907-1910.
87. + T cells. Nat. Immunol. 3, 549-557.
88. HODGE, D.L., MARTINEZ, A., JULIAS, J.G., TAYLOR, L.S., and YOUNG, H.A. (2002). Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol. Cell. Biol. 22, 1742-1753.
89. BEN ASOULI, Y., BANAI, Y., PEL-OR, Y., SHIR, A., and KAEMPFER, R. (2002). Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108, 221-232.
90. FITZGERALD-BOCARSLY, P. (1993). Human natural interferon-alpha producing cells. Pharmacol. Ther. 60, 39-62.
91. + null lymphocytes produce IFN-alpha after stimulation by herpes simplex virus-infected cells. J. Immunol. 145, 1015-1020.
92. PERUSSIA, B., FANNING, V., and TRINCHIERI, G. (1985). A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 4, 120-137.
93. SIEGAL, F.P., KADOWAKI, N., SHODELL, M., FITZGERALD-BOCARSLY, P.A., SHAH, K., HO, S., ANTONENKO, S., and LIU, Y.J. (1999). The nature of the principal type I interferon-producing cells in human blood. Science 284, 1835-1837.
94. (+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194, 1171-1178.
95. BJORCK, P. (2001). Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98, 3520-3526.
96. BRAWAND, P., FITZPATRICK, D.R., GREENFIELD, B.W., BRASEL, K., MALISZIEWSKI, C.R., and DE SMEDT, T. (2002). Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 169, 6711-6719.
97. ITO, T., AMAKAWA, R., KAISHO, T., HEMMI, H., TAJIMA, K., UEHIRA, K., OZAKI, Y., TOMIZAWA, H., AKIRA, S., and FUKUHARA, S. (2002). Interferon-alpha and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195, 1507-1512.
98. ELORANTA, M.L., and ALM, G.V. (1999). Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand. J. Immunol. 49, 391-394.
99. ELORANTA, M.L., SANDBERG, K., and ALM, G.V. (1996). The interferon-alpha/beta responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo. Scand. J. Immunol. 43, 356-360.
100. DIEBOLD, S.S., MONTOYA, M., UNGER, H., ALEX-OPOULOU, L., ROY, P., HASWELL, L.E., AL SHAMKHANI, A., FLAVELL, R., BORROW, P., and REIS, E.S. (2003). Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424, 324-328.
101. FELDMAN, S.B., FERRARO, M., ZHENG, H.M., PATEL, N., GOULD-FOGERITE, S., and FITZGERALD-BOCARSLY, P. (1994). Viral induction of low frequency interferon-alpha producing cells. Virology 204, 1-7.
102. COCCIA, E.M., SEVERA, M., GIACOMINI, E., MONNERON, D., REMOLI, M.E., JULKUNEN, I., CELLA, M., LANDE, R., and UZE, G. (2004). Viral infection and toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34, 796-805.
103. BIRON, C.A., NGUYEN, K.B., PIEN, G.C., COUSENS, L.P., and SALAZAR-MATHER, T.P. (1999). Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220.
104. STOBER, D., SCHIRMBECK, R., and REIMANN, J. (2001). IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J. Immunol. 167, 957-965.
105. MUNDER, M., MALLO, M., EICHMANN, K., and MODOLELL, M. (1998). Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187, 2103-2108.
106. KODUKULA, P., LIU, T., ROOIJEN, N.V., JAGER, M.J., and HENDRICKS, R.L. (1999). Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162, 2895-2905.
107. ORANGE, J.S., WANG, B., TERHORST, C., and BIRON, C.A. (1995). Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045-1056.
108. MONTEIRO, J.M., HARVEY, C., and TRINCHIERI, G. (1998). Role of interleukin-12 in primary influenza virus infection. J. Virol. 72, 4825-4831.
109. GAZZINELLI, R.T., HIENY, S., WYNN, T.A., WOLF, S., and SHER, A. (1993). Interleukin 12 is required for the T lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
110. PIEN, G.C., NGUYEN, K.B., MALMGAARD, L., SATOSKAR, A.R., and BIRON, C.A. (2002). A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169, 5827-5837.
111. (+) T cells provide an early source of IFN-gamma. J. Immunol. 170, 2399-2408.
112. JINDAL, S., and MALKOVSKY, M. (1994). Stress responses to viral infection. Trends Microbial. 2, 89-91.
113. ASEA, A., REHLI, M., KABINGU, E., BOCH, J.A., BARE, O., AURON, P.E., STEVENSON, M.A., and CALDERWOOD, S.K. (2002). Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034.
114. MOGENSEN, T.H., MELCHJORSEN, J., HOLLSBERG, P., and PALUDAN, S.R. (2003). Activation of NF-kappa B in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and I kappa B kinase. J. Immunol. 170, 6224-6233.
115. CAPOBIANCHI, M.R., ANKEL, H., AMEGLIO, F., PAGANELLI, R., PIZZOLI, P.M., and DIANZANI, F. (1992). Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res. Hum. Retrovir. 8, 575-579.
116. ANKEL, H., CAPOBIANCHI, M.R., CASTILLETTI, C., and DIANZANI, F. (1994). Interferon induction by HIV glycoprotein 120: role of the V3 loop. Virology 205, 34-43.
117. LEBON, P. (1985). Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J. Gen. Virol. 66, 2781-2786.
118. ANKEL, H., WESTRA, D.F., WELLING-WESTER, S., and LEBON, P. (1998). Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 251, 317-326.
119. LUND, J., SATO, A., AKIRA, S., MEDZHITOV, R., and IWASAKI, A. (2003). Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520.
120. KRUG, A., LUKER, G.D., BARCHET, W., LEIB, D.A., AKIRA, S., and COLONNA, M. (2003). Herpes simplex virus type 1 (HSV-1) activates murine natural interferon-producing cells (IPC) through toll-like receptor 9. Blood 103, 1433-1437.
121. KANDA, K., KEMPKES, B., BORNKAMM, G.W., VON GABAIN, A., and DECKER, T. (1999). The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines. Biol. Chem. 380, 213-221.
122. ITO, Y., NISHIYAMA, Y., SHIMOKATA, K., NAGATA, I., TAKEYAMA, H., and KUNII, A. (1978). The mechanism of interferon induction in mouse spleen cells stimulated with HVJ. Virology 88, 128-137.
123. ITO, Y., NAGAI, Y., and MAENO, K. (1982). Interferon production in mouse spleen cells and mouse fibroblasts (L cells) stimulated by various strains of Newcastle disease virus. J. Gen. Virol. 62, 349-352.
124. ZENG, J., FOURNIER, P., and SCHIRRMACHER, V. (2002). Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus. Virology 297, 19-30.
125. FOURNIER, P., ZENG, J., and SCHIRRMACHER, V. (2003). Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNA. Int. J. Oncol. 23, 673-680.
126. ITO, Y., and HOSAKA, Y. (1983). Component(s) of Sendai virus that can induce interferon in mouse spleen cells. Infect. Immun. 39, 1019-1023.
127. CHARLEY, B., LAVENANT, L., and DELMAS, B. (1991). Glycosylation is required for coronavirus TGEV to induce an efficient production of IFN alpha by blood mononuclear cells. Scand. J. Immunol. 33, 435-440.
128. HEIL, F., HEMMI, H., HOCHREIN, H., AMPENBERGER, F., KIRSCHNING, C., AKIRA, S., LIPFORD, G., WAGNER, H., and BAUER, S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529.
129. DIEBOLD, S.S., KAISHO, T., HEMMI, H., AKIRA, S., and REIS, E.S. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531.
130. YANG, V.L., REIS, L.R., PAVLOVIC, J., AGUZZI, A., SCHAFER, R., KUMAR, A., WILLIAMS, B.R., AGUET, M., and WEISSMANN, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14, 6095-6106.
131. ZINN, K., KELLER, A., WHITTEMORE, L.A., and MANIATIS, T. (1988). 2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science 240, 210-213.
132. MILLER, J.L., and MARGOT, A.E. (2003). Virus-cell interactions in the induction of type 1 interferon by influenza virus in mouse spleen cells. J. Gen. Virol. 84, 193-202.
133. CAPOBIANCHI, M.R., MALAVASI, F., DI MARCO, P., and DIANZANI, F. (1988). Differences in the mechanism of induction of interferon-alpha by herpes simplex virus and herpes simplex virus-infected cells. Arch. Virol. 103, 219-229.
134. ZENG, J., FOURNIER, P., and SCHIRRMACHER, V. (2002). Stimulation of human natural interferon-alpha response via paramyxovirus hemagglutinin lectin-cell interaction. J. Mol. Med. 80, 443-451.
135. RONG, Q., ALEXANDER, T.S., KOSKI, G.K., and ROSENTHAL, K.S. (2003). Multiple mechanisms for HSV-1 induction of interferon alpha production by peripheral blood mononuclear cells. Arch. Virol. 148, 329-344.
136. TAKEDA, K., and AKIRA, S. (2003). Toll receptors and pathogen resistance. Cell Microbiol. 5, 143-153.
137. VAIDYA, S.A., and CHENG, G. (2003). Toll-like receptors and innate antiviral responses. Curr. Opin. Immunol. 15, 402-407.
138. BARTON, G.M., and MEDZHITOV, R. (2003). Toll-like receptor signaling pathways. Science 300, 1524-1525.
139. MATSUMOTO, M., FUNAMI, K., TANABE, M., OSHIUMI, H., SHINGAI, M., SETO, Y., YAMAMOTO, A., and SEYA, T. (2003). Subcellular localization of toll-like receptor 3 in human dendritic cells. J. Immunol. 171, 3154-3162.
140. AHMAD-NEJAD, P., HACKER, H., RUTZ, M., BAUER, S., VABULAS, R.M., and WAGNER, H. (2002). Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958-1968.
141. O'NEILL, L.A., FITZGERALD, K.A., and BOWIE, A.G. (2003). The toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24, 286-290.
142. FITZGERALD, K.A., ROWE, D.C., BARNES, B.J., CAFFREY, D.R., VISINTIN, A., LATZ, E., MONKS, B., PITHA, P.M., and GOLENBOCK, D.T. (2003). LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J. Exp. Med. 178, 1043-1055.
143. OSHIUMI, H., SASAI, M., SHIDA, K., FUJITA, T., MATSUMOTO, M., and SEYA, T. (2003). TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to roll-like receptor 4 TICAM-1 that induces interferon-β. J. Biol. Chem. 278, 49751-49762.
144. KURT-JONES, E.A., POPOVA, L., KWINN, L., HAYNES, L.M., JONES, L.P., TRIPP, R.A., WALSH, E.E., FREEMAN, M.W., GOLENBOCK, D.T., ANDERSON, L.J., and FINBERG, R.W. (2000). Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1, 398-401.
145. YAMAMOTO, M., SATO, S., HEMMI, H., HOSHINO, K., KAISHO, T., SANJO, J., TAKEUCHI, O., SUGIYAMA, M., OKABE, M., TAKEDA, K., and AKIRA, S. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643.
146. OSHIUMI, H., MATSUMOTO, M., FUNAMI, K., AKAZAWA, T., and SEYA, T. (2003). TICAM-1, an adaptor molecule that participates in toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4, 161-167.
147. TABETA, K., GEORGEL, P., JANSSEN, E., DU, X., HOEBE, K., CROZAT, K., MUDD, S., SHAMEL, L., SOVATH, S., GOODE, J., ALEXOPOULOU, L., FLAVELL, R.A., and BEUTLER, B. (2004). Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101, 3516-3521.
148. (+) dendritic cells only after microbial stimulus. J. Exp. Med. 196, 1307-1319.
149. KADOWAKI, N., HO, S., ANTONENKO, S., MALEFYT, R.W., KASTELEIN, R.A., BAZAN, F., and LIU, Y.J. (2001). Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
150. HEMMI, H., TAKEUCHI, O., KAWAI, T., KAISHO, T., SATO, S., SANJO, H., MATSUMOTO, M., HOSHINO, K., WAGNER, H., TAKEDA, K., and AKIRA, S. (2000). A toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
151. TYTELL, A.A., LAMPSON, G.P., FIELD, A.K., and HILLEMAN, M.R. (1967). Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA). Proc. Natl. Acad. Sci. USA 58, 1719-1722.
152. MARCUS, P.I., and SEKELLICK, M.J. (1977). Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature 266, 815-819.
153. MARCUS, P.I., and SEKELLICK, M.J. (1988). Interferon induction by viruses. XVI. 2-Aminopurine blocks selectively and reversibly an early stage in interferon induction. J. Gen. Virol. 69, 1637-1645.
154. DER, S.D., and LAU, A.S. (1995). Involvement of the double-stranded-RNA- dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. USA 92, 8841-8845.
155. ZAMANIAN-DARYOUSH, M., MOGENSEN, T.H., DIDONATO, J.A., and WILLIAMS, B.R. (2000). NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol. 20, 1278-1290.
156. CLAVELL, L.A., and BRATT, M.A. (1971). Relationship between the ribonucleic acid synthesizing capacity of ultraviolet-irradiated Newcastle disease virus and its ability to induce interferon. J. Virol. 8, 500-508.
157. KATZE, M.G., HE, Y., and GALE, M., Jr. (2002). Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675-687.
158. INOHARA, N., and NUNEZ, G. (2003). NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3, 371-382.
159. GOBL, A.E., FUNA, K., and ALM, G.V. (1988). Different induction patterns of mRNA for IFN-alpha and -beta in human mononuclear leukocytes after in vitro stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J. Immunol. 140, 3605-3609.
160. TRINCHIERI, G., PFLANZ, S., and KASTELEIN, R.A. (2003). The IL-12 family of heterodimeric cytokines. New players in the regulation of T cell responses. Immunity 19, 641-644.
161. BIRON, C.A. (2001). Interferons alpha and beta as immune regulators - a new look. Immunity 14, 661-664.
162. STRENGELL, M., MATIKAINEN, S., SIREN, J., LEHTONEN, A., FOSTER, D., JULKUNEN, I., and SARENEVA, T. (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170, 5464-5469.
163. PALUDAN, S.R. (2002). Interactions between herpes simplex virus and leukocytes: molecular mechanisms and impact on antiviral defense. Curr. Topics Virol. 2, 1-36.
164. TRINCHIERI, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146.
165. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
166. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
167. MANETTI, R., PARRONCHI, P., GIUDIZI, M.G., PICCINNI, M.P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
168. TRIPP, C.S., WOLF, S.F., and UNANUE, E.R. (1993). Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90, 3725-3729.
169. OKAMURA, H., KASHIWAMURA, S., TSUTSUI, H., YOSHIMOTO, T., and NAKANISHI, K. (1998). Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10, 259-264.
170. MALMGAARD, L., and PALUDAN, S.R. (2003). Interferon (IFN)-alpha/beta, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-gamma during infection with herpes simplex virus type 2. J. Gen. Virol. 84, 2497-2500.
171. SARENEVA, T., MATIKAINEN, S., KURIMOTO, M., and JULKUNEN, I. (1998). Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J. Immunol. 160, 6032-6038.
172. ROBINSON, D., SHIBUYA, K., MUI, A., ZONIN, F., MURPHY, E., SANA, T., HARTLEY, S.B., MENON, S., KASTELEIN, R., BAZAN, E., and O'GARRA, A. (1997). IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7, 571-581.
173. NAKAHIRA, M., AHN, H.J., PARK, W.R., GAO, P., TOMURA, M., PARK, C.S., HAMAOKA, T., OHTA, T., KURIMOTO, M., and FUJIWARA, H. (2002). Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced Stat4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activatorprotein 1. J. Immunol. 168, 1146-1153.
174. NAKAHIRA, M., TOMURA, M., IWASAKI, M., AHN, H.J., BIAN, Y., HAMAOKA, T., OHTA, T., KURIMOTO, M., and FUJIWARA, H. (2001). An absolute requirement for Stat4 and a role for IFN-gamma as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex. J. Immunol. 167, 1306-1312.
175. CHANG, J.T., SEGAL, B.M., NAKANISHI, K., OKAMURA, H., and SHEVACH, E.M. (2000). The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur. J. Immunol. 30, 1113-1119.
176. AHN, H.J., MARUO, S., TOMURA, M., MU, J., HAMAOKA, T., NAKANISHI, K., CLARK, S., KURIMOTO, M., OKAMURA, H., and FUJIWARA, H. (1997). A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159, 2125-2131.
177. MATIKAINEN, S., PAANANEN, A., MIETTINEN, M., KURIMOTO, M., TIMONEN, T., JULKUNEN, I., and SARENEVA, T. (2001). IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur. J. Immunol. 31, 2236-2245.
178. COUSENS, L.P., PETERSON, R., HSU, S., DORNER, A., ALTMAN, J.D., AHMED, R., and BIRON, C.A. (1999). Two roads diverged: interferon alpha. J. Exp. Med. 189, 1315-1328.
179. COUSENS, L.P., ORANGE, J.S., SU, H.C., and BIRON, C.A. (1997). Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94, 634-639.
180. NGUYEN, K.B., COUSENS, L.P., DOUGHTY, L.A., PIEN, G.C., DURBIN, J.E., and BIRON, C.A. (2000). Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: stat1 resolves a paradox. Nat. Immunol. 1, 70-76.
181. ROGGE, L., D'AMBROSIO, D., BIFFI, M., PENNA, G., MINETTI, L.J., PRESKY, D.H., ADORINI, L., and SINIGAGLIA, F. (1998). The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161, 6567-6574.
182. CARSON, W.E., ROSS, M.E., BAIOCCHI, R.A., MARIEN, M.J., BOIANI, N., GRABSTEIN, K., and CALIGIURI, M.A. (1995). Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 96, 2578-2582.
183. KASAIAN, M.T., WHITTERS, M.J., CARTER, L.L., LOWE, L.D., JUSSIF, J.M., DENG, B., JOHNSON, K.A., WITEK, J.S., SENICES, M., KONZ, R.F., WURSTER, A.L., DONALDSON, D.D., COLLINS, M., YOUNG, D.A., and GRUSBY, M.J. (2002). IL:21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16, 559-569.
184. TSUNOBUCHI, H., NISHIMURA, H., GOSHIMA, F., DAIKOKU, T., SUZUKI, H., NAKASHIMA, I., NISHIYAMA, Y., and YOSHIKAI, Y. (2000). A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology 275, 57-66.
185. ASHKAR, A.A., and ROSENTHAL, K.L. (2003). Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77, 10168-10171.
186. PARRISH-NOVAK, J., FOSTER, D.C., HOLLY, R.D., and CLEGG, C.H. (2002). Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukocyte Biol. 72, 856-863.
187. WURSTER, A.L., RODGERS, V.L., SATOSKAR, A.R., WHITTERS, M.I., YOUNG, D.A., COLLINS, M., and GRUSBY, M.J. (2002). Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 196, 969-977.
188. BROMBACHER, F., KASTELEIN, R.A., and ALBER, G. (2003). Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24, 207-212.
189. OPPMANN, B., LESLEY, R., BLOM, B., TIMANS, J.C., XU, Y., HUNTE, B., VEGA, F., YU, N., WANG, J., SINGH, K., ZONIN, F., VAISBERG, E., CHURAKOVA, T., LIU, M., GORMAN, D., WAGNER, J., ZURAWSKI, S., LIU, Y., ABRAMS, J.S., MOORE, K.W., RENNICK, D., WAAL-MALEFYT, R., HANNUM, C., BAZAN, J.F., and KASTELEIN, R.A. (2000). Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725.
190. (+) T cells. Immunity 16, 779-790.
191. TAKEDA, A., HAMANO, S., YAMANAKA, A., HANADA, T., ISHIBASHI, T., MAK, T.W., YOSHIMURA, A., and YOSHIDA, H. (2003). Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of Stat1 during initial Th1 commitment. J. Immunol. 170, 4886-4890.
192. CARR, J.A., ROGERSON, J.A., MULQUEEN, M.J., ROBERTS, N.A., and NASH, A.A. (1999). The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40. J. Interferon Cytokine Res. 19, 1145-1152.
193. ORANGE, J.S., and BIRON, C.A. (1996). Characterization of early IL-12, IFN-alpha/beta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156, 4746-4756.
194. HARANDI, A.M., SVENNERHOLM, B., HOLMGREN, J., and ERIKSSON, K. (2001). Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol. 75, 6705-6709.
195. PIEN, G.C., SATOSKAR, A.R., TAKEDA, K., AKIRA, S., and BIRON, C.A. (2000). Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J. Immunol. 165, 4787-4791.
196. WALKER, W., ASTE-AMEZAGA, M., KASTELEIN, R.A., TRINCHIERI, G., and HUNTER, C.A. (1999). IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J. Immunol. 162, 5894-5901.
197. + T cells upon NKR-P1 cross-linking. J. Exp. Med. 183, 2391-2396.
198. + T cells. J. Exp. Med. 186, 1957-1963.
199. RAJAGOPALAN, S., FU, J., and LONG, E.O. (2001). Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167, 1877-1881.
200. ORTALDO, J.R., and YOUNG, H.A. (2003). Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J. Immunol. 170, 1763-1769.
201. SOUTTO, M., ZHOU, W., and AUNE, T.M. (2002). Cutting edge: distal regulatory elements are required to achieve selective expression of IFN-gamma in Th1/Tc1 effector cells. J. Immunol. 169, 6664-6667.
202. HARANDI, A.M., ERIKSSON, K., and HOLMGREN, J. (2003). A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77, 953-962.
203. ASHKAR, A.A., BAUER, S., MITCHELL, W.J., VIEIRA, I., and ROSENTHAL, K. (2003). Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77, 8948-8956.